Skip to main content
. Author manuscript; available in PMC: 2013 Oct 22.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Aug 11;18(4):575–583. doi: 10.1016/j.bbmt.2011.08.003

Table 3. Overall Frequency of Hyperlipidemia.

Frequency of hyperlipidemia in allogeneic HSCT recipients. Cutoffs were derived from current ATP-III treatment guidelines.

Pre-Transplantation Post-Transplantation
N % N %
Total cholesterol 0 -199 mg/dL 381 68.0 201 26.6
≥ 200 mg/dL 179 32.0 556 73.4
Triglyceride 0 -199 mg/dL 348 60.7 201 27.5
≥ 200 mg/dL 225 39.3 531 72.5